However, tumor growth at day 24 after challenge was inhibited by 35% with IP2 alone while the combination of IP2 with the TL9 SLP induced a 60% tumor growth reduction (Fig. 6c) and led to a prolonged overall survival (Fig. 6d). This evidence concerns the gene IKBKG and neoplasm.